InflaRx develops new therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application.

Jena, DE
Size (employees)
9 (est)
InflaRx was founded in 2006 and is headquartered in Jena, DE
Report incorrect company information

InflaRx Office Locations

InflaRx has offices in Planegg and Jena
Planegg, DE
5 Semmelweisstraße
Show all (2)
Report incorrect company information

InflaRx Financials and Metrics

InflaRx Revenue

InflaRx's revenue was reported to be €108 k in FY, 2017 which is a 53.2% decrease from the previous period.

Revenue (FY, 2017)

108 k

Revenue growth (FY, 2016 - FY, 2017), %


Net income (FY, 2017)

(24.2 m)

EBIT (FY, 2017)

(19.4 m)

Market capitalization (18-Jul-2018)

898.2 m

Closing share price (18-Jul-2018)


Cash (31-Dec-2017)

123.3 m
InflaRx's current market capitalization is $898.2 m.
EURFY, 2015FY, 2016FY, 2017


134 k231 k108 k

Revenue growth, %


General and administrative expense

438 k1.8 m5.1 m

R&D expense

3.5 m5.3 m14.4 m
EURFY, 2015FY, 2016FY, 2017


3.3 m29.1 m123.3 m

Current Assets

3.5 m29.4 m124 m


109 k131 k173 k

Total Assets

3.6 m29.5 m124.2 m
EURFY, 2015FY, 2016FY, 2017

Net Income

(4.9 m)(8.9 m)(24.2 m)

Depreciation and Amortization

40 k33 k71 k

Cash From Operating Activities

(3.3 m)(5 m)(12.2 m)

Cash From Investing Activities

(13 k)(53 k)(167 k)
EURY, 2017


12 k

Financial Leverage

1 x

P/E Ratio

(13.5 )
Show all financial metrics
Report incorrect company information

InflaRx News and Updates

Report incorrect company information

InflaRx Company Life and Culture

Report incorrect company information